Prevalence of Amyloidosis in Trauma Patients
ConditionAmyloidosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorConsorci Sanitari de l'Alt Penedès i Garraf
About this trial
This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness > 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP > 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
Ability to cooperate in the necessary evaluations.
Signed informed consent for inclusion in the study, either by the participant or their legal representative.
Disqualifiers
None
Trial population
Patients included in the waiting list for scheduled trauma surgery
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Traumatologic surgery
Procedure/SurgeryPatients undergoing trauma surgery
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Amyloidosis
Proportion of patients undergoing scheduled orthopedic surgery who are diagnosed with amyloidosis.
Time frame
One monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov